{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:22:50Z","timestamp":1780503770024,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472437"],"award-info":[{"award-number":["81472437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672590"],"award-info":[{"award-number":["81672590"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602438"],"award-info":[{"award-number":["81602438"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12325-021-01941-1","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T11:03:46Z","timestamp":1636110226000},"page":"360-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Human Epididymis Protein\u00a04 and Lewis\u00a0y Enhance Chemotherapeutic Resistance in Epithelial Ovarian Cancer Through the p38\u00a0MAPK Pathway"],"prefix":"10.1007","volume":"39","author":[{"given":"Jian","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liancheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"1941_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","volume":"41","author":"PM Webb","year":"2017","unstructured":"Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3\u201314.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"13","key":"1941_CR2","first-page":"3695","volume":"63","author":"I Hellstrom","year":"2003","unstructured":"Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63(13):3695\u2013700.","journal-title":"Cancer Res"},{"issue":"6","key":"1941_CR3","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein\u00a04 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65(6):2162\u20139.","journal-title":"Cancer Res"},{"issue":"9","key":"1941_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/14737140.2017.1360138","volume":"17","author":"G Scaletta","year":"2017","unstructured":"Scaletta G, Plotti F, Luvero D, et al. The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review. Expert Rev Anticancer Ther. 2017;17(9):827\u201339.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"1941_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.currproblcancer.2018.06.001","volume":"43","author":"L Zhang","year":"2019","unstructured":"Zhang L, Chen Y, Wang K. Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis. Curr Probl Cancer. 2019;43(2):135\u201344.","journal-title":"Curr Probl Cancer"},{"issue":"1","key":"1941_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","volume":"12","author":"V Dochez","year":"2019","unstructured":"Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res. 2019;12(1):28.","journal-title":"J Ovarian Res"},{"issue":"26","key":"1941_CR7","doi-asserted-by":"publisher","first-page":"12957","DOI":"10.1073\/pnas.91.26.12957","volume":"91","author":"K Kitamura","year":"1994","unstructured":"Kitamura K, Stockert E, Garin-Chesa P, et al. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generated against synthetic and natural Le(y) determinants. Proc Natl Acad Sci U S A. 1994;91(26):12957\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1941_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/glycob\/8.4.393","volume":"8","author":"CH Hokke","year":"1998","unstructured":"Hokke CH, Neeleman AP, Koeleman CA, van den Eijnden DH. Identification of an \u03b13-fucosyltransferase and a novel \u03b12-fucosyltransferase activity in cercariae of the schistosome Trichobilharzia ocellata: biosynthesis of the Fuc\u03b11\u21922Fuc\u03b11\u21923[Gal(NAc)\u03b21\u21924]GlcNAc sequence. Glycobiology. 1998;8(4):393\u2013406.","journal-title":"Glycobiology"},{"issue":"4","key":"1941_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1189\/jlb.68.4.511","volume":"68","author":"M Dettke","year":"2000","unstructured":"Dettke M, Palfi G, Loibner H. Activation-dependent expression of the blood group-related Jewis Y antigen on peripheral blood granulocytes. J Leukoc Biol. 2000;68(4):511\u20134.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"1941_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.biochi.2010.02.012","volume":"92","author":"LM Yan","year":"2010","unstructured":"Yan LM, Lin B, Zhu LC, et al. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin alpha5beta1 with the Lewis Y-structure on transfection of the alpha1,2-fucosyltransferase gene. Biochimie. 2010;92(7):852\u20137.","journal-title":"Biochimie"},{"issue":"10","key":"1941_CR11","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.3390\/ijms11103748","volume":"11","author":"F Li","year":"2010","unstructured":"Li F, Lin B, Hao Y, et al. Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors. Int J Mol Sci. 2010;11(10):3748\u201359.","journal-title":"Int J Mol Sci"},{"key":"1941_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1756-9966-28-154","volume":"28","author":"J Liu","year":"2009","unstructured":"Liu J, Lin B, Hao Y, et al. Lewis\u00a0y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K\/Akt signaling pathway. J Exp Clin Cancer Res. 2009;28:154.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"1941_CR13","doi-asserted-by":"publisher","first-page":"e68994","DOI":"10.1371\/journal.pone.0068994","volume":"8","author":"H Zhuang","year":"2013","unstructured":"Zhuang H, Gao J, Hu Z, Liu J, Liu D, Lin B. Co-expression of Lewis\u00a0y antigen with human epididymis protein\u00a04 in ovarian epithelial carcinoma. PLoS ONE. 2013;8(7):e68994.","journal-title":"PLoS ONE"},{"key":"1941_CR14","unstructured":"NCCN Clinical Practice Guidelines in Oncology-Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer (Version 3.2021). .http:\/\/www.nccn.org. Accessed 9 Sept 2021"},{"issue":"2","key":"1941_CR15","first-page":"830","volume":"5","author":"LC Zhu","year":"2015","unstructured":"Zhu LC, Gao J, Hu ZH, et al. Membranous expressions of Lewis\u00a0y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer. Am J Cancer Res. 2015;5(2):830\u201343.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"1941_CR16","first-page":"237","volume":"55","author":"FA Sinicrope","year":"1995","unstructured":"Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995;55(2):237\u201341.","journal-title":"Cancer Res"},{"issue":"9","key":"1941_CR17","first-page":"1808","volume":"58","author":"CD Lu","year":"1998","unstructured":"Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58(9):1808\u201312.","journal-title":"Cancer Res"},{"issue":"5","key":"1941_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/bio.2015.0032","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers LJ, Ardlie K, Barcus M, et al. A novel approach to high-quality postmortem tissue procurement: the GTEx project. Biopreserv Biobank. 2015;13(5):311\u20139.","journal-title":"Biopreserv Biobank"},{"issue":"7738","key":"1941_CR19","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1038\/s41586-018-0722-x","volume":"565","author":"J Barretina","year":"2019","unstructured":"Barretina J, Caponigro G, Stransky N, et al. Addendum: the cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2019;565(7738):E5\u20136.","journal-title":"Nature"},{"issue":"9","key":"1941_CR20","doi-asserted-by":"publisher","first-page":"12251","DOI":"10.1007\/s13277-016-5080-4","volume":"37","author":"S Gao","year":"2016","unstructured":"Gao S, Zhu L, Feng H, et al. Gene expression profile analysis in response to alpha1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells. Tumour Biol. 2016;37(9):12251\u201362.","journal-title":"Tumour Biol"},{"issue":"3","key":"1941_CR21","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3892\/or.2016.4926","volume":"36","author":"L Zhu","year":"2016","unstructured":"Zhu L, Guo Q, Jin S, et al. Analysis of the gene expression profile in response to human epididymis protein\u00a04 in epithelial ovarian cancer cells. Oncol Rep. 2016;36(3):1592\u2013604.","journal-title":"Oncol Rep"},{"issue":"1","key":"1941_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.18632\/oncotarget.6327","volume":"7","author":"L Zhu","year":"2016","unstructured":"Zhu L, Zhuang H, Wang H, et al. Overexpression of HE4 (human epididymis protein\u00a04) enhances proliferation, invasion and metastasis of ovarian cancer. Oncotarget. 2016;7(1):729\u201344.","journal-title":"Oncotarget"},{"issue":"1","key":"1941_CR23","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"Suppl 4","key":"1941_CR24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"1","key":"1941_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/or.2014.3549","volume":"33","author":"H Wang","year":"2015","unstructured":"Wang H, Zhu L, Gao J, Hu Z, Lin B. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells. Oncol Rep. 2015;33(1):403\u201312.","journal-title":"Oncol Rep"},{"key":"1941_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1476-4598-13-243","volume":"13","author":"H Zhuang","year":"2014","unstructured":"Zhuang H, Tan M, Liu J, et al. Human epididymis protein\u00a04 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells. Mol Cancer. 2014;13:243.","journal-title":"Mol Cancer"},{"key":"1941_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12935-019-0864-4","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Deng L, Zhuang H, et al. Interaction of HE4 and ANXA2 exists in various malignant cells-HE4-ANXA2-MMP2 protein complex promotes cell migration. Cancer Cell Int. 2019;19:161.","journal-title":"Cancer Cell Int"},{"key":"1941_CR28","doi-asserted-by":"crossref","unstructured":"Wang A, Jin C, Tian X, Wang Y, Li H. Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK\/STAT3 pathway. Biol Open. 2019; 8(9):bio043570.","DOI":"10.1242\/bio.043570"},{"issue":"1","key":"1941_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13048-018-0402-3","volume":"11","author":"D Liu","year":"2018","unstructured":"Liu D, Kong D, Li J, et al. HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect. J Ovarian Res. 2018;11(1):47.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1941_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/jog.13181","volume":"43","author":"S Lee","year":"2017","unstructured":"Lee S, Choi S, Lee Y, Chung D, Hong S, Park N. Role of human epididymis protein\u00a04 in chemoresistance and prognosis of epithelial ovarian cancer. J Obstet Gynaecol Res. 2017;43(1):220\u20137.","journal-title":"J Obstet Gynaecol Res"},{"issue":"12","key":"1941_CR31","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/apm.12625","volume":"124","author":"M Aarenstrup Karlsen","year":"2016","unstructured":"Aarenstrup Karlsen M, Hogdall C, Nedergaard L, et al. HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer. APMIS. 2016;124(12):1038\u201345.","journal-title":"APMIS"},{"key":"1941_CR32","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/srep03574","volume":"4","author":"RG Moore","year":"2014","unstructured":"Moore RG, Hill EK, Horan T, et al. HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Sci Rep. 2014;4:3574.","journal-title":"Sci Rep"},{"issue":"5","key":"1941_CR33","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.4049\/jimmunol.180.5.3347","volume":"180","author":"M Nonaka","year":"2008","unstructured":"Nonaka M, Ma BY, Murai R, et al. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. J Immunol. 2008;180(5):3347\u201356.","journal-title":"J Immunol"},{"issue":"9","key":"1941_CR34","first-page":"2777","volume":"5","author":"M Tan","year":"2015","unstructured":"Tan M, Zhu L, Zhuang H, et al. Lewis Y antigen modified CD47 is an independent risk factor for poor prognosis and promotes early ovarian cancer metastasis. Am J Cancer Res. 2015;5(9):2777\u201387.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"1941_CR35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s12032-014-0920-9","volume":"31","author":"J Gao","year":"2014","unstructured":"Gao J, Hu Z, Liu J, et al. Expression of CD147 and Lewis\u00a0y antigen in ovarian cancer and their relationship to drug resistance. Med Oncol. 2014;31(5):920.","journal-title":"Med Oncol"},{"issue":"4","key":"1941_CR36","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s13277-014-2841-9","volume":"36","author":"H Zhuang","year":"2015","unstructured":"Zhuang H, Tan M, Liu J, et al. The expression of annexin II and Lewis\u00a0y antigen in ovarian epithelial tumors and the correlation between them. Tumour Biol. 2015;36(4):2343\u20139.","journal-title":"Tumour Biol"},{"issue":"66","key":"1941_CR37","doi-asserted-by":"publisher","first-page":"110064","DOI":"10.18632\/oncotarget.22617","volume":"8","author":"M Cai","year":"2017","unstructured":"Cai M, Jin S, Deng L, et al. Lewis\u00a0y antigen promotes p27 degradation by regulating ubiquitin-proteasome activity. Oncotarget. 2017;8(66):110064\u201376.","journal-title":"Oncotarget"},{"issue":"22","key":"1941_CR38","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120(22):3446\u201356.","journal-title":"Cancer"},{"issue":"1","key":"1941_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-016-0240-0","volume":"9","author":"JR Ribeiro","year":"2016","unstructured":"Ribeiro JR, Schorl C, Yano N, et al. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells. J Ovarian Res. 2016;9(1):28.","journal-title":"J Ovarian Res"},{"issue":"6","key":"1941_CR40","first-page":"3355","volume":"38","author":"Y Hao","year":"2017","unstructured":"Hao Y, Zhu L, Yan L, et al. c-Fos mediates alpha1, 2-fucosyltransferase 1 and Lewis\u00a0y expression in response to TGF-beta1 in ovarian cancer. Oncol Rep. 2017;38(6):3355\u201366.","journal-title":"Oncol Rep"},{"issue":"4","key":"1941_CR41","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3892\/ijo.2015.2886","volume":"46","author":"X Shan","year":"2015","unstructured":"Shan X, Aziz F, Tian LL, Wang XQ, Yan Q, Liu JW. Ginsenoside Rg3-induced EGFR\/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4\/LeY expression. Int J Oncol. 2015;46(4):1667\u201376.","journal-title":"Int J Oncol"},{"key":"1941_CR42","doi-asserted-by":"crossref","unstructured":"Hybel TE, Dietrichs D, Sahana J, et al. Simulated microgravity influences VEGF, MAPK, and PAM signaling in prostate cancer cells. Int J Mol Sci. 2020;21(4):1263.","DOI":"10.3390\/ijms21041263"},{"key":"1941_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.canlet.2018.09.026","volume":"439","author":"S Wang","year":"2018","unstructured":"Wang S, Xiao Z, Hong Z, et al. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA. Cancer Lett. 2018;439:78\u201390.","journal-title":"Cancer Lett"},{"key":"1941_CR44","doi-asserted-by":"publisher","first-page":"108957","DOI":"10.1016\/j.biopha.2019.108957","volume":"115","author":"J Guo","year":"2019","unstructured":"Guo J, Chen M, Ai G, Mao W, Li H, Zhou J. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047. Biomed Pharmacother. 2019;115:108957.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1941_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13058-019-1130-3","volume":"21","author":"J Cairns","year":"2019","unstructured":"Cairns J, Ingle JN, Kalari KR, et al. The lncRNA MIR2052HG regulates ERalpha levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1. Breast Cancer Res. 2019;21(1):47.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1941_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ymthe.2016.12.018","volume":"25","author":"M Sun","year":"2017","unstructured":"Sun M, Nie FQ, Zang C, et al. The pseudogene DUXAP8 promotes non-small-cell lung cancer cell proliferation and invasion by epigenetically silencing EGR1 and RHOB. Mol Ther. 2017;25(3):739\u201351.","journal-title":"Mol Ther"},{"issue":"37","key":"1941_CR47","doi-asserted-by":"publisher","first-page":"39941","DOI":"10.18632\/oncotarget.5402","volume":"6","author":"K Stamatakis","year":"2015","unstructured":"Stamatakis K, Jimenez-Martinez M, Jimenez-Segovia A, et al. Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression. Oncotarget. 2015;6(37):39941\u201359.","journal-title":"Oncotarget"},{"issue":"5","key":"1941_CR48","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3892\/or.2014.3472","volume":"32","author":"E Parra","year":"2014","unstructured":"Parra E, Gutierrez L, Ferreira J. Association of increased levels of TGF-beta1 and p14ARF in prostate carcinoma cell lines overexpressing Egr-1. Oncol Rep. 2014;32(5):2191\u20138.","journal-title":"Oncol Rep"},{"issue":"57","key":"1941_CR49","doi-asserted-by":"publisher","first-page":"96865","DOI":"10.18632\/oncotarget.18292","volume":"8","author":"AN Shajahan-Haq","year":"2017","unstructured":"Shajahan-Haq AN, Boca SM, Jin L, et al. EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer. Oncotarget. 2017;8(57):96865\u201384.","journal-title":"Oncotarget"},{"issue":"9","key":"1941_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41419-019-1882-9","volume":"10","author":"T Tang","year":"2019","unstructured":"Tang T, Zhu Q, Li X, et al. Protease Nexin I is a feedback regulator of EGF\/PKC\/MAPK\/EGR1 signaling in breast cancer cells metastasis and stemness. Cell Death Dis. 2019;10(9):649.","journal-title":"Cell Death Dis"},{"key":"1941_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2018.00211","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Li D, Wang Y, et al. Beta-defensin 2 and 3 promote bacterial clearance of Pseudomonas aeruginosa by inhibiting macrophage autophagy through downregulation of early growth response gene-1 and c-FOS. Front Immunol. 2018;9:211.","journal-title":"Front Immunol"},{"issue":"8","key":"1941_CR52","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1158\/1541-7786.MCR-18-1109","volume":"17","author":"B Parmakhtiar","year":"2019","unstructured":"Parmakhtiar B, Burger RA, Kim JH, Fruehauf JP. HIF inactivation of p53 in ovarian cancer can be reversed by topotecan, restoring cisplatin and paclitaxel sensitivity. Mol Cancer Res. 2019;17(8):1675\u201386.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"1941_CR53","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.7150\/thno.29673","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, Qi Z, Yin H, Yang G. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1alpha-mediated regulation of apoptosis and autophagy. Theranostics. 2019;9(4):1096\u2013114.","journal-title":"Theranostics"},{"key":"1941_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biochi.2017.10.002","volume":"144","author":"W Zhang","year":"2018","unstructured":"Zhang W, Yuan W, Song J, Wang S, Gu X. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1alpha. Biochimie. 2018;144:21\u20137.","journal-title":"Biochimie"},{"issue":"32","key":"1941_CR55","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1038\/onc.2017.82","volume":"36","author":"CJ Ko","year":"2017","unstructured":"Ko CJ, Lan SW, Lu YC, et al. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Oncogene. 2017;36(32):4597\u2013609.","journal-title":"Oncogene"},{"key":"1941_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2017.09.030","volume":"412","author":"H Xu","year":"2018","unstructured":"Xu H, Lin F, Wang Z, et al. CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Lett. 2018;412:69\u201380.","journal-title":"Cancer Lett"},{"issue":"1","key":"1941_CR57","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/0008-5472.CAN-17-0836","volume":"78","author":"A Ooki","year":"2018","unstructured":"Ooki A, Del Carmen Rodriguez Pena M, Marchionni L, et al. YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells. Cancer Res. 2018;78(1):168\u201381.","journal-title":"Cancer Res"},{"issue":"4","key":"1941_CR58","first-page":"1688","volume":"24","author":"JL Yu","year":"2020","unstructured":"Yu JL, Gao X. MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy. Eur Rev Med Pharmacol Sci. 2020;24(4):1688\u201396.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"1941_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41389-019-0165-8","volume":"8","author":"F Liang","year":"2019","unstructured":"Liang F, Ren C, Wang J, et al. The crosstalk between STAT3 and p53\/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug\/MAPK\/PI3K\/AKT-mediated regulation of EMT and autophagy. Oncogenesis. 2019;8(10):59.","journal-title":"Oncogenesis"},{"key":"1941_CR60","first-page":"113896","volume":"2020","author":"NH Patel","year":"1896","unstructured":"Patel NH, Xu J, Saleh T, Wu Y, Lima S, Gewirtz DA. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells. Biochem Pharmacol. 1896;2020:113896.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"1941_CR61","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/15548627.2019.1671643","volume":"16","author":"TY Lin","year":"2020","unstructured":"Lin TY, Chan HH, Chen SH, et al. BIRC5\/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy. 2020;16(7):1296\u2013313.","journal-title":"Autophagy"},{"issue":"10","key":"1941_CR62","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1080\/15548627.2019.1596479","volume":"15","author":"J New","year":"2019","unstructured":"New J, Thomas SM. Autophagy-dependent secretion: mechanism, factors secreted, and disease implications. Autophagy. 2019;15(10):1682\u201393.","journal-title":"Autophagy"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01941-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T06:42:10Z","timestamp":1666766530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01941-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1941"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01941-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}